Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |